Miami Cancer Institute, part of Baptist Health South Florida, announced its Third Annual Precision Oncology Symposium, which will be held February 7-8, 2025, at Loews Coral Gables Hotel in Florida. The one-and-a-half-day symposium provides an overview of recent advances in the treatment of solid tumors with novel targeted agents and treatment combinations, as well as evolving molecular-based system therapies.
“The 2025 symposium features an impressive roster of speakers and presentations,” said Manmeet Ahluwalia, M.D., FASCO, MBA, Fernandez Family Foundation Endowed Chair in Cancer Research, Chief of Medical Oncology, and Chief Scientific Officer & Deputy Director at Miami Cancer Institute. “Attendees will hear from luminaries in the fields of oncology and I could not be more excited to bring this caliber of experts in precision oncology to South Florida.”
Manmeet Ahluwalia, M.D., FASCO, MBA
Topics discussed at the symposium include: evolving therapeutic strategies in the treatment of solid tumor malignancies as well as new molecular and targeted treatments; new targeted diagnostic and therapeutic strategies for lung cancer, breast cancer, gastrointestinal tumors, genitourinary tumors, head and neck tumors, melanoma, sarcomas and brain tumors; and the role and timing of diagnostic tests, molecular profiling and potential combinations of targeted therapy treatment options.
Miami Cancer Institute’s Third Annual Precision Oncology Symposium is an educational event and Baptist Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Attendees will include oncologists, pathologists, radiation oncologists, palliative care staff, oncology and hematology nurses, pharmacists, medical students, residents and fellows in training, research staff and other allied healthcare members interested in the treatment of patients with solid tumor malignancies.
To learn more about the symposium and to register, please visit here.
For updates on the Third Annual Precision Oncology Symposium, follow #MCIPrecisionOncology on social media as well as Miami Cancer Institute on X (Twitter) at @MiamiCancerInst.
About Miami Cancer Institute
Miami Cancer Institute brings to South Florida access to personalized clinical treatments and comprehensive support services delivered with unparalleled compassion. No other cancer program in the region has the combination of cancer-fighting expertise and advanced technology—including the first proton therapy center in South Florida, Latin America and the Caribbean, and one of the only radiation oncology programs in the world with each of the newest radiation therapies in one place—to diagnose and deliver precise cancer treatments that achieve the best outcomes and improve the lives of cancer patients. The Institute offers an impressive roster of established community oncologists and renowned experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. Selected as Florida’s only member of the Memorial Sloan Kettering Cancer (MSK) Alliance, Miami Cancer Institute is part of a meaningful clinical collaboration that affords patients in South Florida access to innovative treatments and ensures that the standards of care developed by their multidisciplinary disease management teams match those at MSK. For more information, please visit here.
Miami Cancer Institute is part of Baptist Health Cancer Care, the largest cancer program in South Florida, with locations from the Florida Keys to the Palm Beaches.
